What Has Been the Progress and Growth of the Albumin And Creatinine Tests Market in Recent Years?
The albumin and creatinine tests market has seen considerable growth due to a variety of factors.
• In recent times, there has been substantial growth in the market size of albumin and creatinine tests. The market, which was worth $2.95 billion in 2024, is expected to expand to $3.61 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 22.6%.
Several factors are contributing to this immense growth during the historic period. They include the escalating prevalence of chronic kidney diseases (CKD) and diabetes, heightened awareness of preliminary diagnostic tools for kidney health, rising usage of point-of-care testing gadgets, growth in the healthcare infrastructure of emerging markets, and advancements in technology related to diagnostic testing procedures.
What Is The Expected Growth In The Albumin And Creatinine Tests Market?
The albumin and creatinine tests market is expected to maintain its strong growth trajectory in upcoming years.
• The market for albumin and creatinine tests is predicted to experience tremendous expansion in the upcoming years, reaching a value of $8.05 billion in 2029 with a compound annual growth rate (CAGR) of 22.2%.
Several factors are contributing to this predicted growth in the forecast period, including increased demand for remote and home-based diagnostic tools, incorporation of AI in diagnostic equipment for precision testing, an increased focus on preventative healthcare and early detection of diseases, the adoption of personalized medicine strategies, and government funding for kidney health awareness initiatives. Looking ahead, we can expect to see trends such as the creation of automated and mobile diagnostic systems, the rising use of telemedicine for diagnostic solutions, advancements in biomarkers for precise renal function tests, the development of lab-on-chip technologies for immediate care, and growing partnerships between diagnostic firms and research institutions.
What Main Forces Are Fueling Expansion In The Albumin And Creatinine Tests Market?
The escalating prevalence of chronic kidney diseases (CKD) is anticipated to fuel the expansion of the albumin and creatinine tests market. CKD signifies a steady deterioration of renal function over time, where kidneys fail to adequately filter waste and surplus fluids from the blood, leading to a toxin build up and potential complications in various bodily systems. The growth in chronic kidney diseases prevalence is attributed to an increase in risk factors such as diabetes, hypertension, and obesity. By measuring protein levels, like albumin, in urine and examining kidney function via creatinine levels, albumin and creatinine tests aid in the detection and monitoring of chronic kidney diseases, thereby facilitating timely intervention and management of kidney damage. For example, as per a report published by Kidney Research UK, a non-profit organization based in the UK, in June 2023, approximately 7.2 million people, representing over 10% of the population in the UK, are living with chronic kidney disease, with 3.25 million in advanced stages and 3.9 million in early stages. This number is estimated to rise to 7.61 million by 2033. Therefore, the increasing prevalence of chronic kidney disease is spurring the growth of the albumin and creatinine tests market.
What Are The Primary Segments In The Global Albumin And Creatinine Tests Market?
The albumin and creatinine tests market covered in this report is segmented –
1) By Product: Dipsticks And Kits, Analyzers, Cartridges, Reagents, Other Products
2) By Type: Blood And Urine Creatinine, Urine Albumin, Glycated Albumin
3) By End-User: Hospital And Clinics, Diagnostic Laboratories, Research Laboratories And Institutes, Other End-User
Subsegments:
1) By Dipsticks And Kits: Urine Dipstick Tests, Microalbumin Test Kits, Point-of-Care Test Kits
2) By Analyzers: Automated Urine Analyzers, Benchtop Analyzers, Handheld Analyzers
3) By Cartridges: Single-Use Cartridges, Multi-Parameter Cartridges
4) By Reagents: Colorimetric Reagents, Enzymatic Reagents, Immunoassay Reagents
5) By Other Products: Control Solutions, Calibration Standards, Accessories And Consumables
Pre-Book The Albumin And Creatinine Tests Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Albumin And Creatinine Tests Market?
Leading businesses in the albumin and creatinine tests market are focusing on cutting-edge technologies like smartphone-based testing. This technology is utilized to examine urine samples to calculate a patient's albumin-to-creatinine ratio, a crucial factor in forecasting chronic kidney disease. Smartphone-based testing involves the application of mobile technology, including apps and accessories, to carry out diagnostic examinations and review health information, delivering fast and readily available results. For example, Healthy-io, a health tech firm from the UK, obtained authorization from the US Food and Drug Administration (FDA) in July 2022 for its innovative Minuteful Kidney Test, a diagnostic tool powered by artificial intelligence and designed for smartphones. This convenient and non-invasive test lets patients perform the test at their own homes using just a smartphone and a unique test strip, supplying instant results. Consequently, it offers early detection of kidney disease, allowing patients to keep track of their wellbeing and seek prompt medical help, potentially minimizing the frequency of doctor appointments.
Who Are the Key Players In The Albumin And Creatinine Tests Market?
Major companies operating in the albumin and creatinine tests market are:
• Siemens Healthineers Company
• Roche Diagnostics GmbH
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• FUJIFILM Corporation
• Laboratory Corporation of America Holdings
• Sysmex Corporation
• Ortho Clinical Diagnostics Inc.
• Randox Laboratories Ltd.
• Nova Biomedical Corporation
• Eagle Biosciences Inc.
• Sekisui Diagnostics LLC
• BTNX Inc.
• RayBiotech Life Inc.
• ARKRAY Inc.
• PromoCell GmbH
• Arbor Assays Inc.
• Teco Diagnostics Inc.
• J. Mitra & Co. Pvt. Ltd.
• Anamol Laboratories Pvt. Ltd.
What Is The Most Dominant Region In The Albumin And Creatinine Tests Market?
North America was the largest region in the albumin and creatinine tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin and creatinine tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
